Protein Expression Market Set to Surge to $4.6 Billion by 2026 at a 10.2% CAGR

The protein expression market has witnessed significant growth in recent years, driven by advancements in biotechnology and an increasing demand for therapeutic proteins. In 2018, the global protein expression market was valued at $2,121 million and is projected to reach $4,611 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.

Read More Here: https://www.alliedmarketresearch.com/protein-expression-market-A06098

Protein Expression Market Growth Factors
Several factors contribute to the robust expansion of the protein expression market:
1. Rising Prevalence of Chronic Diseases: The increasing incidence of chronic ailments such as cancer, diabetes, and multiple sclerosis has heightened the need for therapeutic proteins, including peptide hormones, vaccines, monoclonal antibodies, and therapeutic enzymes. These proteins offer enhanced quality, accuracy, and efficiency in biologics production.

2. Advancements in Biotechnology: Significant progress in genetic engineering and recombinant technologies has facilitated the large-scale expression and isolation of recombinant proteins. The development of recombinant proteins capable of entering cells has opened new avenues in therapeutic medicine by targeting intracellular mechanisms or substituting intracellular enzymes.

3. Increased Research and Development Spending: There has been a notable rise in investments toward protein research, further propelling the protein expression market. This surge in funding supports the development of innovative solutions and applications in various sectors, including healthcare and industrial processes.

Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/A06098

Protein Expression Market Segmentation
The protein expression market is segmented based on product, application, and region.
By Product:
• Reagents: These are essential for the protein expression process and include acids, bases, acrylamides, buffers, cell lysis solutions, detergents, protease inhibitors, and solvents. The repetitive purchase of reagents for various applications is expected to boost market growth.
• Expression Vectors: Plasmids or viruses used to introduce specific genes into target cells, facilitating the production of desired proteins.
• Competent Cells: Bacterial cells treated to allow the uptake of foreign DNA, crucial for cloning and protein expression experiments.
• Instruments: Equipment such as bioreactors, spectrophotometers, and chromatography systems used in the protein expression and purification process.
• Services: Custom protein expression services offered by specialized companies to support research and development activities.
By Application:
• Therapeutic: The production of therapeutic proteins to treat various diseases. This segment was the highest contributor to the market in 2018.
• Industrial: Utilization of proteins in industrial processes, such as enzyme production for manufacturing applications.
• Research: Use of protein expression in academic and commercial research to study protein functions and interactions.
By Region:
• North America: Holds a significant share of the protein expression market, attributed to the presence of major pharmaceutical and biotechnology companies, along with substantial investments in research and development.
• Europe: Notable for its focus on protein therapeutics and substantial investments in biotechnology.
• Asia-Pacific: Expected to witness significant growth, offering lucrative opportunities due to improvements in healthcare facilities, rising disposable incomes, and rapid economic development. This region is anticipated to register the highest growth rate during the forecast period.
• LAMEA (Latin America, Middle East, and Africa): Emerging markets with growing investments in biotechnology and healthcare infrastructure.

Key Players in the Protein Expression Market
The protein expression market features several key players driving innovation and competition:
• Agilent Technologies, Inc.
• Becton, Dickinson & Company
• Bio-Rad Laboratories
• GenScript Biotech Corporation
• LifeSensors Inc.
• Merck KGaA
• Promega Corporation
• QIAGEN N.V.
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.

These companies are at the forefront of developing and providing products and services that cater to the diverse needs of the protein expression market.

The protein expression market is poised for substantial growth, driven by the increasing demand for therapeutic proteins, advancements in biotechnology, and heightened research and development activities. As the prevalence of chronic diseases continues to rise, and with ongoing innovations in protein expression technologies, the market is expected to expand further, offering new opportunities for stakeholders across various sectors.

Procure Complete Report: https://www.alliedmarketresearch.com/checkout-final/4933fc7910ef2302677dd4eae00c0a2b

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.